101140-06-1 Usage
Uses
Used in Pharmaceutical Industry:
Amentoflavone is used as a therapeutic agent for its diverse pharmacological properties, including anti-inflammatory, anti-viral, anti-cancer, anti-diabetic, antioxidant, and neuroprotective effects. Its interaction with enzymes and biological systems, such as PDE4 inhibition and GABA receptor binding, makes it a promising candidate for the development of new drugs.
Used in Drug Delivery Systems:
To overcome the limitations of amentoflavone's low water solubility and bioavailability, novel drug delivery systems are being researched and developed. These systems aim to enhance the delivery, bioavailability, and therapeutic outcomes of amentoflavone, improving its efficacy in various applications. Various organic and metallic nanoparticles are being explored as carriers for amentoflavone delivery, potentially enhancing its pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 101140-06-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,1,4 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 101140-06:
(8*1)+(7*0)+(6*1)+(5*1)+(4*4)+(3*0)+(2*0)+(1*6)=41
41 % 10 = 1
So 101140-06-1 is a valid CAS Registry Number.
InChI:InChI=1/C30H18O10/c31-15-4-1-13(2-5-15)24-12-23(38)29-21(36)10-20(35)27(30(29)40-24)17-7-14(3-6-18(17)33)25-11-22(37)28-19(34)8-16(32)9-26(28)39-25/h1-12,31-36H
101140-06-1Relevant articles and documents
Preparation method of natural biflavones such as I3,II8-Biapgienin and Ridiculuflavone A
-
, (2017/08/28)
The present invention belongs to the field of new compound preparation methods and medicine research, and particularly relates to a preparation method of natural biflavones such as I3,II8-Biapgienin and Ridiculuflavone A. According to the present invention, the two compounds such as I3,II8-Biapgienin and Ridiculuflavone A are firstly synthesized, wherein I3,II8-Biapgienin has good anti-depression activity, good anti-tumor activity, good anti-oxidation activity, good anti-inflammatory activity and good anti-liver injury activity, further has inhibition activity on estrogen receptors, benzodiazepine receptors and CYP, and has broad prospects in the fields of drug development and application.